Rachel McMinn
Chief Executive Officer at Neurogene Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Neurogene Inc., 2 years.
Neurogene Inc.
Director · Chief Executive Officer
Chief executive roles
Neurogene Inc.
· Chief Executive Officer
Since December 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Neurogene Inc. | Open-market sale | −3,352 | $22.07 | $73,979 |
| Feb 20, 2026 | Neurogene Inc. | Grant or award | +25,900 | — | — |
| Mar 26, 2025 | Neurogene Inc. | Grant or award | +23,900 | — | — |
| Nov 22, 2024 | Neurogene Inc. | Open-market purchase | +47,500 | $20.40 | $969,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.